Author:
Zou Tianxiang,Yang Min,Chen Zhuohui,Xie Haiqing,Huang Jing,Qin Yue,Liu Furu,Chen Haiyu,Xu Xuelei,Chen Jindong,Tang Hui,Xiang Hui,Wu Haishan,Liu MingHui,Luo Wenbo,Liu Jieyu,Teng Ziwei
Abstract
Abstract
Background
Patients with bipolar disorder (BD) show abnormalities in glucolipid metabolism and reproductive hormone levels, which are of concern in women with BD. This study was dedicated to investigating the glucolipid and reproductive hormone levels of female patients, and to preliminarily investigating their relationships with cognition.
Methods
A total of 58 unmedicated female BD patients, 61 stable-medicated female BD patients, and 63 healthy controls (HC) were recruited in this study. Serum glycolipid indexes and reproductive hormones were measured. Cognitive function was assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Stroop Color-Word Test (Stroop test).
Results
Patients with BD showed significant cognitive impairment (p < 0.05), which was not affected by medication. Triglycerides (TG), luteinizing hormone (LH), and high-density lipoprotein cholesterol (HDL-c) were altered in stable-medicated BD patients. In addition, regression analysis showed that progesterone (PRGE) and prolactin (PRL) were negatively associated with cognitive performance in stable-medicated BD patients.
Conclusions
Female BD patients may have cognitive deficits and abnormal levels of glycolipids and reproductive hormones. And abnormal levels of glycolipids and reproductive hormones may be associated with cognitive dysfunction in female BD patients.
Funder
the National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC